Bibliography
- Shastry BS : Pharmacogenetics and the concept of individualized medicine.Pharmacogenomics J.6(1) , 16–21 (2006).
- Eichelbaum M , Ingelman-SundbergM, EvansWE: Pharmacogenomics and individualized drug therapy.Annu. Rev. Med.57 , 119–137 (2006).
- Ingelman-Sundberg M , SimSC, GomezA, Rodriguez-AntonaC: Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.Pharmacol. Ther.116(3) , 496–526 (2007).
- Ingelman-Sundberg M : Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future.Trends Pharmacol. Sci.25(4) , 193–200 (2004).
- Lamba JK , LinYS, SchuetzEG, ThummelKE: Genetic contribution to variable human CYP3A-mediated metabolism.Adv. Drug. Deliv. Rev.54 , 1271–1294 (2002).
- van Schaik RH : CYP450 pharmacogenetics for personalizing cancer therapy.Drug Resist. Updat.11(3) , 77–98 (2008).
- Goldstein JA : Clinical relevance of genetic polymorphisms in the human CYP2C subfamily.Br. J. Clin. Pharmacol.52(4) , 349–355 (2001).
- Kirchheiner J , SeeringerA: Clinical implications of pharmacogenetics of cytochrome P450 drug metabolizing enzymes.Biochim. Biophys. Acta.1770(3) , 489–494 (2007).
- Veenstra DL , BloughDK, HigashiMK et al.: CYP2C9 haplotype structure in European American warfarin patients and association with clinical outcomes.Clin. Pharmacol. Ther.77(5) , 353–364 (2005).
- Sim SC , RisingerC, DahlML et al.: A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants.Clin. Pharmacol. Ther.79(1) , 103–113 (2006).
- Ingelman-Sundberg M : Genetic polymorphisms of cytochrome P4502D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity.Pharmacogenomics J.5(1) , 6–13 (2005).
- Ragoussis J : Genotyping technologies for all.Drug Discov. Today Technologies.3(2) , 115–122 (2006).
- Ragoussis J , ElvidgeGP, KaurK, ColellaS: Matrix-assisted laser desorption/ionisation, time-of-flight mass spectrometry in genomics research.PLoS Genet.2(7) , E100 (2006).
- Tost J , GutIG: Genotyping single nucleotide polymorphisms by MALDI mass spectrometry in clinical applications.Clin. Biochem.38 , 335–350 (2005).
- van den Boom D , EhrichM: Discovery and identification of sequence polymorphisms and mutations with MALDI-TOF MS.Methods Mol. Biol.366 , 287–306 (2007).
- McGuigan FE , RalstonSH: Single nucleotide polymorphism detection: allelic discrimination using TaqMan.Psychiatr. Genet.12(3) , 133–136 (2002).
▪ Websites
- Human Cytochrome P450 Allele Nomenclature Committee www.cypalleles.ki.se
- iPLEX™ Gold Application Guide Version 1, Revision 1. December 7 (2007) www.sequenom.com/iplex
- NCBI SNP dbSNP www.ncbi.nlm.nih.gov/projects/SNP
- Ensembl Genome Browser www.ensembl.org/index.html
- BLAST: Basic Local Alignment Search Tool http://blast.ncbi.nlm.nih.gov/Blast.cgi
- Sequenom RealSNP™ Assay Database www.realsnp.com